BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24480297)

  • 1. Perioperative beta-blocker use and survival in lung cancer patients.
    Cata JP; Villarreal J; Keerty D; Thakar DR; Liu DD; Sood AK; Gottumukkala V
    J Clin Anesth; 2014 Mar; 26(2):106-17. PubMed ID: 24480297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Wang HM; Liao ZX; Komaki R; Welsh JW; O'Reilly MS; Chang JY; Zhuang Y; Levy LB; Lu C; Gomez DR
    Ann Oncol; 2013 May; 24(5):1312-9. PubMed ID: 23300016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.
    Al-Niaimi A; Dickson EL; Albertin C; Karnowski J; Niemi C; Spencer R; Shahzad MM; Uppal S; Saha S; Rice L; Nally AM
    Gynecol Oncol; 2016 Dec; 143(3):521-525. PubMed ID: 27693123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Oh MS; Guzner A; Wainwright DA; Mohindra NA; Chae YK; Behdad A; Villaflor VM
    Clin Lung Cancer; 2021 Jan; 22(1):e57-e62. PubMed ID: 32900613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-blockers on survival of lung cancer patients: a systematic review and meta-analysis.
    Coelho M; Squizzato A; Cassina N; Marino F; Ribeiro LV; Cosentino M
    Eur J Cancer Prev; 2020 Jul; 29(4):306-314. PubMed ID: 31609808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.
    Yap A; Lopez-Olivo MA; Dubowitz J; Pratt G; Hiller J; Gottumukkala V; Sloan E; Riedel B; Schier R
    Br J Anaesth; 2018 Jul; 121(1):45-57. PubMed ID: 29935594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
    Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
    Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
    Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    Latif MJ; Tan KS; Molena D; Huang J; Bott MJ; Park BJ; Adusumilli PS; Rusch VW; Bains MS; Downey RJ; Jones DR; Isbell JM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2469-2477.e10. PubMed ID: 30902468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study.
    Wu HL; Tai YH; Chan MY; Tsou MY; Chen HH; Chang KY
    BMJ Open; 2019 May; 9(5):e027618. PubMed ID: 31152035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study.
    Sakamoto A; Yagi K; Okamura T; Harada T; Usuda J
    Sci Rep; 2019 Mar; 9(1):5217. PubMed ID: 30914694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence.
    Sivanesan S; Taskén KA; Grytli HH
    JAMA Netw Open; 2022 Jan; 5(1):e2145230. PubMed ID: 35080602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
    Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.